Skip to main content
PLUS THERAPEUTICS, Inc.
  • Company
  • Pipeline
  • Partnerships
  • Investor Relations
  • Contact Us

Watch Now: ReSPECT™ Glioblastoma Clinical Trial Update Webinar

Select Page
  • Company
  • Pipeline
  • Partnerships
  • Investor Relations
  • Contact Us
  • Overview
    • Press Releases
    • News
    • Events
    • Presentations
    • Reports & Filings
      • Quarterly Results
      • SEC Filings
      • Annual Reports
      • Meetings & Proxy Materials
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
      • Analyst Coverage
    • Governance
      • Board Committees
      • Corporate Governance Materials
      • Executive Team
      • Board of Directors
    • Resources
      • Information Request
      • Email Alerts
      • RSS Feeds
      • Videos
      • Photos
x
Investor Menu

Presentations

  • Overview
    • Press Releases
    • News
    • Events
    • Presentations
    • Reports & Filings
      • Quarterly Results
      • SEC Filings
      • Annual Reports
      • Meetings & Proxy Materials
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
      • Analyst Coverage
    • Governance
      • Board Committees
      • Corporate Governance Materials
      • Executive Team
      • Board of Directors
    • Resources
      • Information Request
      • Email Alerts
      • RSS Feeds
      • Videos
      • Photos
Presentation RSS Feed (opens in new window)

Contact Investors Relations

PLUS THERAPEUTICS, Inc.
4200 Marathon Blvd., Suite 200, Austin, TX 78756 USA
Tel: +1.737.255.7194
ir@plustherapeutics.com

RSS Feeds

  • Press Release(opens in new window)
  • Presentation(opens in new window)
  • Event(opens in new window)
  • SEC Filing(opens in new window)

Investor Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At PLUS THERAPEUTICS, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to PLUS THERAPEUTICS to send you the requested Investor Email Alert updates.

* Required

*
*
 
Enter the code shown above.
*
Unsubscribe

Email Alert Sign Up Confirmation

  • Company
  • Pipeline
  • Partnerships
  • Investor Relations
  • Contact Us

HEADQUARTERS
4200 Marathon Blvd.
Suite 200
Austin, TX 78756 USA

Tel: +1.737.255.7194
Fax: +1.858.450.4335

GENERAL INFORMATION
info@plustherapeutics.com

BUSINESS DEVELOPMENT
bd@plustherapeutics.com

HUMAN RESOURCES
hr@plustherapeutics.com

INVESTOR/PUBLIC RELATIONS
ir@plustherapeutics.com

  • Facebook
  • Instagram
  • LinkedIn
  • StockTwits
  • Twitter
  • Yahoo
  • YouTube
  • Privacy Policy
  • Terms of Use
  • Forward Looking Statement
  • Social Media Guidelines
Copyright © 2020 Plus Therapeutics, Inc. All rights reserved. Plus Therapeutics, RNL, DocePLUS, DoxoPLUS, and ReSPECT are trademarks of Plus Therapeutics, Inc.
Powered By Q4 Inc. 5.49.0.3 (opens in new window)